Management of thrombotic thrombocytopenic purpura without plasma exchange: the Jehovah’s Witness experience
WORLDWIDE REPORTS

Management of thrombotic thrombocytopenic purpura without plasma exchange: the Jehovah’s Witness experience

George JN
Blood Adv.
January 01,2017
The University of Oklahoma Health Sciences Center
Share this
Abstract

TTP in Jehovah’s Witness patients has been managed successfully without PEX.This experience, plus new TTP treatments, may make it possible for patients who are not Jehovah’s Witnesses to avoid PEX in the future.